Search Results - "van der Zee, Hessel H."

Refine Results
  1. 1

    The Cystic Sponge Anus by van der Zee, Hessel H., Aarts, Pim

    Published in Case reports in dermatology (01-01-2024)
    “…Abstract Introduction: A peculiar spongy appearance of the perianal skin was observed in a patient who underwent wide excision surgery for inguinal and gluteal…”
    Get full text
    Journal Article
  2. 2

    New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes by van der Zee, Hessel H., MD, Jemec, Gregor B.E., MD

    “…Current classifications for hidradenitis suppurativa (HS), such as the Hurley staging system, are not very specific. The absence of rigorous classifications is…”
    Get full text
    Journal Article
  3. 3

    Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model by Vossen, Allard R J V, van der Zee, Hessel H, Prens, Errol P

    Published in Frontiers in immunology (14-12-2018)
    “…The pathogenesis of hidradenitis suppurativa (HS) is not fully understood. This systematic review examined the latest evidence for molecular inflammatory…”
    Get full text
    Journal Article
  4. 4

    Damage in hidradenitis suppurativa: receiving the deserved attention by Aarts, Pim, Zee, Hessel H.

    Published in British journal of dermatology (1951) (01-09-2022)
    “…Linked Article: Fritsche et al. Br J Dermatol 2022; 187:288–294…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Hidradenitis suppurativa: A retrospective study of 846 Dutch patients to identify factors associated with disease severity by Schrader, Anne M.R., MD, Deckers, Inge E., MD, van der Zee, Hessel H., MD, PhD, Boer, Jurr, MD, PhD, Prens, Errol P., MD, PhD

    “…Background Few comprehensive studies exist on the epidemiology of hidradenitis suppurativa, a very distressing skin disease. Objective We sought to identify…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments by van der Zee, Hessel H., Laman, Jon D., Boer, Jurr, Prens, Errol P.

    Published in Experimental dermatology (01-10-2012)
    “…Hidradenitis suppurativa (HS) is an inflammatory, debilitating follicular skin disease with recurring flare‐ups. The painful, deep‐seated, inflamed lesions in…”
    Get full text
    Journal Article
  9. 9

    Deroofing: A tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions by van der Zee, Hessel H., MD, Prens, Errol P., MD, PhD, Boer, Jurr, MD, PhD

    “…Background Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease, often refractory to treatment. Patients with HS and dermatologists are in need…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement by Deckers, Inge E., MD, van der Zee, Hessel H., MD, PhD, Boer, Jurr, MD, PhD, Prens, Errol P., MD, PhD

    “…Background The reported mean age of onset of hidradenitis suppurativa (HS) is between 20 and 24 years. Prepubertal onset is thought to be rare. Objective We…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    High prevalence of hidradenitis suppurativa in patients with perianal fistula by Ardon, Christine B., Molenaar, Charlotte, van Straalen, Kelsey R., Scholtes, Violette C., Prens, Errol P., van der Zee, Hessel H.

    “…Background Perianal fistula is an abnormal communication between the anal canal and perianal skin. Hidradenitis suppurativa (HS) is a chronic,…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial by Vossen, Allard R.J.V., van Doorn, Martijn B.A., van der Zee, Hessel H., Prens, Errol P.

    “…Effective anti-inflammatory treatments for hidradenitis suppurativa (HS) are limited. To evaluate the efficacy and short-term safety of apremilast in patients…”
    Get full text
    Journal Article